General Information of the Compound
Compound ID
CP0035593
Compound Name
(3S,4S)-3-hydroxy-4-[(2S)-2-[(3S,4S)-3-hydroxy-6-methyl-4-[(2S)-3-methyl-2-[(2S)-3-methyl-2-(3-methylbutanamido)butanamido]butanamido]heptanamido]propanamido]-6-methylheptanoic acid
    Show/Hide
Synonyms
AC1NUZ3J
L-Valinamide, N-(3-methyl-1-oxobutyl)-L-valyl-N-(4-((2-((1-(2-carboxy-1-hydroxyethyl)-3-methylbutyl)amino)-1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl)-, (1S-(1R*,2R*,4(R*(R*(R*)))))-
N-Isovaleryl-L-valyl-L-valyl-3-hydroxy-6-methyl-gamma-aminoheptanoyl-L-alanyl-3-hydroxy-6-methyl-gamma-aminoheptanoic acid
Pepstatin
    Show/Hide
Structure
Formula
C34H63N5O9
Molecular Weight
685.904
Canonical SMILES
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O
    Show/Hide
InChI
InChI=1S/C34H63N5O9/c1-17(2)12-23(37-33(47)31(21(9)10)39-34(48)30(20(7)8)38-27(42)14-19(5)6)25(40)15-28(43)35-22(11)32(46)36-24(13-18(3)4)26(41)16-29(44)45/h17-26,30-31,40-41H,12-16H2,1-11H3,(H,35,43)(H,36,46)(H,37,47)(H,38,42)(H,39,48)(H,44,45)/t22-,23-,24-,25-,26-,30-,31-/m0/s1
    Show/Hide
InChIKey
FAXGPCHRFPCXOO-LXTPJMTPSA-N
Physicochemical Property
logP
1.4672
Rotatable Bonds
22
Heavy Atom Count
48
Polar Areas
223.26
Hydrogen Bond Donor Count
8
Hydrogen Bond Acceptor Count
8
Complexity
48

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5478883
SID: 49683285
ChEMBL ID
CHEMBL296588
Clinical Information about the Compound
Drug 1 ( Pepstatin )
Drug Name Pepstatin
Indication
Malaria
Terminated
Target(s)
Plasmodium Plasmepsin 2 (Malaria PLA2)
Inhibitor
Plasmodium Plasmepsin 1 (Malaria PLA1)
Inhibitor
Plasmodium Cysteine protease falcipain-2 (Malaria CPF2)
Inhibitor